Brought to you by the International Journal of Pharmaceutical Compounding
August 5, 2005 Volume 2, Issue 29
  In This Issue
 
  About
  CompoundingToday
 
  Free Resources
 
  Subscriber
  Resources
 
 
 
 
 
 
CT.com/USP Special Offer

CompoundingToday.com and The United States Pharmacopeia are teaming up to bring great tools to the compounding professional!

For a limited time, get one year of full access to CompoundingToday.com AND a copy of USP's new Pharmacist's Pharmacopeia together for only $450 - a savings of $75 from the costs if purchased separately!

The USP Pharmacists� Pharmacopeia is the first dedicated reference from the U.S. Pharmacopeia for pharmacy practitioners and students and provides comprehensive and critical information that will significantly enhance the knowledge and application of pharmacy practices.

CompoundingToday.com is the compounding professional's best source for compounding formulas, tools, and information with the goal of having everything available for the compounder at the touch of a key; from calculations/calculators to formulations to physiochemical data to technology to cutting-edge methods to background and supporting information.

Find out more about the Pharmacist's Pharmacopeia and this great offer at www.compoundingtoday.com/USPBundle

 
  Letter from the Editor
Loyd V. Allen, Jr., Ph.D., R.Ph.

Editorial: The Seven Categories of Compounding

Soon to be published in the USP-NF and the USP-Pharmacists' Pharmacopeia will be a revision to USP General Chapter <1075> Good Compounding Practices, related to the seven categories of compounding. These have been presented at several different national meetings but I thought I would comment on them in this column.

First of all, since the categories are contained in chapter <1075>, which is a number greater than 1000, they are informational. If you recall, a General Chapter numbered less than 1000 is an enforceable standard and one numbered greater than 1000 is informational (but can still be enforceable). Some may also recall that "USP Chapter <1206> Sterile Drug Products for Home Use' was the one that was revised and is now "USP Chapter <797> Pharmaceutical Compounding-Sterile Preparations" and what was formerly "USP Chapter <1161> Pharmacy Compounding Practices" is now "USP Chapter <795> Pharmaceutical Compounding-Nonsterile Preparations". Both of these chapters were formerly "informational", but now are enforceable. More on the general chapters for compounding in later editorials but now let's look at the categories in compounding.

The introductory paragraph to this section of <1075> explains that these compounding categories are intended to provide an understanding among compounders when different forms of preparations are compounded. Inherent in these categories is the understanding that there are levels of training associated with each category.

The seven categories are as follows:

  1. Nonsterile-Simple
  2. Nonsterile-Complex
  3. Sterile-Risk Level 1
  4. Sterile-Risk Level 2
  5. Sterile-Risk Level 3
  6. Radiopharmaceuticals
  7. Veterinary

Category 1: Nonsterile-Simple generally consists of the mixing of two or more commercial products. It is an activity that should be capably done by any college of pharmacy graduate without any additional training. Obviously such factors as solubility, pH changes, etc. must be considered prior to the activity, but it is generally a relatively simple process.

Category 2: Nonsterile-Complex generally consists of compounding with bulk drug substances or when complex calculations are required. Depending upon the education received by the pharmacist, some will be knowledgeable and capable of performing complex nonsterile compounding. However, when working with microgram doses of potent drugs, extreme caution must be observed and adequate precautions taken to ensure the safety of the personnel involved.

Category 3: Sterile-Risk Level 1 is the same as Low-Risk Level in USP general chapter <797> Pharmacy Compounding-Sterile Preparations. This category involves only the transfer, measuring, and mixing manipulations with closed or sealed packaging systems that are performed promptly and attentively and are compounded with aseptic manipulations entirely within ISO Class 5 or better air quality using only sterile ingredients, products, components and devices.

Category 4: Sterile-Risk Level 2 is the same as Medium-Risk Level in USP general chapter <797> Pharmacy Compounding-Sterile Preparations. This category generally involves multiple individual or small doses of sterile products for administration either to multiple patients or to one patient on multiple occasions. The process includes complex aseptic manipulations other than the single-volume transfer and may be of unusually long duration. These preparations do not contain broad-spectrum bacteriostatic substances and are administered over several days. Adequate training and validation is critical for this category of compounding due to the potential risks involved.

Category 5: Sterile-Risk Level 3 is the same as High-Risk Level in USP general chapter <797> Pharmacy Compounding-Sterile Preparations. Generally, this category includes the use of nonsterile ingredients, devices and/or exposure to air quality inferior to ISO Class 5, etc. prior to terminal sterilization. This is obviously the most critical of all 7 categories because of the potential harm to patients. This category of compounding should be done ONLY by those pharmacists that have been adequately trained and validated for this category of compounding.

Category 6: Radiopharmaceuticals includes the compounding of any radioactive pharmaceutical. Training and validation not only in aseptic manipulations is generally required, but also proper training in the handling of radioactive agents.

Category 7: Veterinary compounding is compounding of preparations for animals. It is in a category of its own because of the unique set of knowledge that is important related to animals and how they handle and metabolize drugs. Training in veterinary compounding, both nonsterile and sterile, is important for the safety of the animals as well as for the personnel involved in the compounding.

Purpose and Potential Uses of the Categories

It is obvious that pharmacy compounding is growing and becoming more and more complex. Issues that are being addressed include quality, training, accreditation, certification, etc. In looking at these issues, it is apparent that if one is only doing nonsterile-complex compounding that this pharmacist does not necessarily need to have special training in sterile compounding. If the pharmacy wishes to become accredited, they should not be held to Category 5 standards for sterile compounding, etc. if they are only doing nonsterile complex compounding. Also, it may or may not be necessary for a category 4 and 5 pharmacy to meet all the different criteria for a category 2 pharmacy, depending upon how they are utilized. These are not "levels" of compounding, but rather they are "categories" of compounding. In other words, there is the capability of matching the activities of the compounding pharmacy with the different categories of compounding for accreditation, training, etc.

If certification ever comes into play, then there is the potential for certification in different compounding categories, rather than having to demonstrate a certain level of competence in all the categories.

If insurance carriers wish, they may be able to use these categories to match the risk with the compounding activities of the pharmacy. Why should Category 5 insurance rates be levied on a Category 1 or Category 2 compounding pharmacy? This may provide an opportunity of lower insurance rates for those compounding pharmacies doing Category 1, 2 and 3 compounding only.

In summary, these categories may change over time as more experience is gained in their utility and application. They may be combined in different forms, as the Pharmacy Compounding Accreditation Board has done. Compounding categories are simply a tool that can be used to enhance pharmacy compounding


Loyd V. Allen, Jr., Ph.D., R.Ph
Editor-in-Chief

 
Hypothyroidism Articles Added to the CT Database

This week, over 30 articles were added to the CT.com literature search database related to the treatment of hypothyroidism, with focus on the controversy over treating with levothyroxine alone or combination of levothyroxine/liothyronine (as covered in IJPC 9(4)).

Here is just a sample:

  • American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists. Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium. Thyroid 2004; 14(7): 486.
  • Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M et al. Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 2005; 142(6): 412-424.
  • Gaby AR. Sub-laboratory hypothyroidism and the empirical use of Armour thyroid. Altern Med Rev 2004; 9(2): 157-179.
  • Hennemann G, Docter R, Visser TJ et al. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: Proof of principle. Thyroid 2004; 14(4): 271-275.
  • Saravaran P, Simmons DJ, Greenwood R et al. Partial substitution of thyroxine (T4) with triiodothyronine in patients on T4 replacement therapy: Results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90(2): 805-812.

 
Press Releases

EPS TampAlerT® Labels
EPS®, Inc. is pleased to release their line of TampAlerT® Labels. It's their latest advancement in tamper-evident labeling. TampAlerT Labels are ideal when visual immediate tamper detection is essential.

They're ideal for:

  • vials, bottles and jars.
  • boxes, envelopes, paper & plastic bags
  • blood & urine collection tubes
  • evidence containers for law enforcement
  • confidential or valuable documents or possessions

Each TampAlerT Label has been constructed from a specially formulated, acrylic adhesive which bonds quickly to practically all surfaces. Just peel and stick the label where you wish. The labels are designed with tiny serrated edges, instantly tearing if an attempt is made to remove it---indicating a security breach.

TampAlerT Labels can withstand temperatures from -20 degrees F to over 300 degrees F and are available in both strips and rolls. Eight different sets of labels are in stock and are available for immediate shipment (with text stating Evidence, Lab Sample, Security Seal to name just a few). Labels can be custom imprinted and designed to meet your exact specifications.

For samples or more information, please contact EPS at:

EPS , INC.
70 Industrial Drive
Ivyland, PA 18974

Phone: (800) 523-8966 (215) 396-8600
Fax: (800) 323-8933 (215) 396-6662

Web Site: http://www.medi-dose.com
E-Mail: info@medi-dose.com

 
Compounding Tip of the Week

To ensure correct volumes are obtained when using plastic syringes for measuring, check each new lot of syringes as follows:

  1. Tare the balance with the syringe on the weighing pan.
  2. Fill the syringe with water at room temperature to a predetermined mark (such as 5.0 mL).
  3. Place the filled syringe on the balance and determine the weight of the water.
  4. The water in the syringe should weigh in grams, the volume to which it was filled in milliliters (5.0 g in our example)
  5. If the syringe is not calibrated properly, i.e., the markings on the syringe barrel are incorrect, return the syringes and obtain a new lot.

Note: Syringes are designed for the "administration" of finished drug dosage forms, not for compounding. However, it is common practice in hospital intravenous admixture programs and other compounding pharmacies, to use them for measuring volumes during compounding. It is the responsibility of the compounder to ensure they are measuring correctly.

Copyright 2005
International Journal of Pharmaceutical Compounding
395 North 10th Street, Beaumont TX 77702-1901
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
info@compoundingtoday.com